Edit search
Case studies showing clinical signs and management of cutane…
Case studies showing clinical signs and management of cutaneous toxicity of the MEK1%2F2 inhibitor AZD6244 %28ARRY-142886%29 in patients with solid tumours.
Case studies showing clinical signs and management of cutaneous toxicity of the MEK1%2F2 inhibitor AZD6244 %28ARRY-142886%29 in patients with solid tumours.
Article, Chapter
Authors: I.M.E. Desar
Publication: Volume:49, Issue:1
Published: 2010
ISSN: 0284-186X
Browse related articles
  Print copies at your library
  Request a copy of this item
Cite this item